{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:55:23Z","timestamp":1787320523329,"version":"build-2736575974"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T00:00:00Z","timestamp":1517356800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007637","name":"Departamento Administrativo de Ciencia, Tecnolog\u00eda e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["691 of 2014"],"award-info":[{"award-number":["691 of 2014"]}],"id":[{"id":"10.13039\/100007637","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2018.00005","type":"journal-article","created":{"date-parts":[[2018,1,30]],"date-time":"2018-01-30T23:20:05Z","timestamp":1517354405000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":38,"title":["Plasma Levels of Myonectin But Not Myostatin or Fibroblast-Derived Growth Factor 21 Are Associated with Insulin Resistance in Adult Humans without Diabetes Mellitus"],"prefix":"10.3389","volume":"9","author":[{"given":"Freddy J. K.","family":"Toloza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose O.","family":"Mantilla-Rivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C.","family":"P\u00e9rez-Matos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria L.","family":"Ricardo-Silgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha C.","family":"Morales-Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jairo A.","family":"Pinz\u00f3n-Cort\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maritza","family":"P\u00e9rez-Mayorga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha L.","family":"Ar\u00e9valo-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Tolosa-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos O.","family":"Mendivil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,1,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.bone.2015.02.008","article-title":"Skeletal muscle as an endocrine organ: PGC-1\u03b1, myokines and exercise","volume":"80","author":"Schnyder","year":"2015","journal-title":"Bone"},{"key":"B2","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/387083a0","article-title":"Regulation of skeletal muscle mass in mice by a new TGF superfamily member","volume":"387","author":"McPherron","year":"1997","journal-title":"Nature"},{"key":"B3","doi-asserted-by":"publisher","first-page":"40235","DOI":"10.1074\/jbc.M004356200","article-title":"Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation","volume":"275","author":"Thomas","year":"2000","journal-title":"J Biol Chem"},{"key":"B4","doi-asserted-by":"publisher","first-page":"30","DOI":"10.2337\/db08-0943","article-title":"Increased secretion and expression of myostatin in skeletal muscle from extremely obese women","volume":"58","author":"Hittel","year":"2009","journal-title":"Diabetes"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.2337\/db08-0245","article-title":"Loss-of-function mutation in myostatin reduces tumor necrosis factor production and protects liver against obesity-induced insulin resistance","volume":"58","author":"Wilkes","year":"2009","journal-title":"Diabetes"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1073\/pnas.1525795113","article-title":"Anti-myostatin antibody increases muscle mass and strength and improves insulin sensitivity in old mice","volume":"113","author":"Camporez","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e108230","DOI":"10.1371\/journal.pone.0108230","article-title":"Serum myostatin is reduced in individuals with metabolic syndrome","volume":"9","author":"Han","year":"2014","journal-title":"PLoS One"},{"key":"B8","doi-asserted-by":"publisher","first-page":"11968","DOI":"10.1074\/jbc.M111.336834","article-title":"Myonectin (CTRP15), a novel myokine that links skeletal muscle to systemic lipid homeostasis","volume":"287","author":"Seldin","year":"2012","journal-title":"J Biol Chem"},{"key":"B9","doi-asserted-by":"publisher","first-page":"E88","DOI":"10.1210\/jc.2011-1743","article-title":"Effects of aerobic exercise training on C1q tumor necrosis factor \u03b1-related protein isoform 5 (myonectin): association with insulin resistance and mitochondrial DNA density in women","volume":"97","author":"Lim","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B10","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0167-4781(00)00067-1","article-title":"Identification of a novel FGF, FGF-21, preferentially expressed in the liver","volume":"1492","author":"Nishimura","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"B11","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1146\/annurev-physiol-021115-105339","article-title":"Understanding the physiology of FGF21","volume":"78","author":"Fisher","year":"2016","journal-title":"Annu Rev Physiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.cmet.2013.12.017","article-title":"Irisin and FGF21 are cold-induced endocrine activators of brown fat function in humans","volume":"19","author":"Lee","year":"2014","journal-title":"Cell Metab"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1210\/jc.2013-1250","article-title":"Circulating levels of FGF-21 in obese youth: associations with liver fat content and markers of liver damage","volume":"98","author":"Giannini","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.2337\/db07-1476","article-title":"Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans","volume":"57","author":"Zhang","year":"2008","journal-title":"Diabetes"},{"key":"B15","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/ijo.2014.76","article-title":"Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients","volume":"39","author":"Gallego-Escuredo","year":"2015","journal-title":"Int J Obes (Lond)"},{"key":"B16","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.clnu.2016.04.027","article-title":"FGF19 and FGF21 serum concentrations in human obesity and type 2 diabetes behave differently after diet- or surgically-induced weight loss","volume":"36","author":"G\u00f3mez-Ambrosi","year":"2017","journal-title":"Clin Nutr"},{"key":"B17","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.cmet.2013.08.005","article-title":"The Effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes","volume":"18","author":"Gaich","year":"2013","journal-title":"Cell Metab"},{"key":"B18","first-page":"79","volume-title":"Designing Clinical Research: An Epidemiologic Approach","author":"Hulley","year":"2013"},{"key":"B19","first-page":"E214","article-title":"Glucose clamp technique: a method for quantifying insulin secretion and resistance","volume":"237","author":"deFronzo","year":"1979","journal-title":"Am J Physiol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1515\/CCLM.2009.263","article-title":"Glomerular filtration rate measurement and prediction equations","volume":"47","author":"Soares","year":"2009","journal-title":"Clin Chem Lab Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1210\/jcem.85.7.6661","article-title":"Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans","volume":"85","author":"Katz","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"B23","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1136\/bmj.300.6725.680-a","article-title":"Analysis of serial measurements in medical research","volume":"300","author":"Matthews","year":"1990","journal-title":"Br Med J"},{"key":"B24","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0168-8227(99)00116-3","article-title":"Validation of the insulin sensitivity index (ISI(0,120)): comparison with other measures","volume":"47","author":"Gutt","year":"2000","journal-title":"Diabetes Res Clin Pract"},{"key":"B25","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/ijo.2014.166","article-title":"Leptin administration activates irisin-induced myogenesis via nitric oxide-dependent mechanisms, but reduces its effect on subcutaneous fat browning in mice","volume":"39","author":"Rodr\u00edguez","year":"2015","journal-title":"Int J Obes"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1249\/MSS.0b013e3181e0b9a8","article-title":"Myostatin decreases with aerobic exercise and associates with insulin resistance","volume":"42","author":"Hittel","year":"2010","journal-title":"Med Sci Sports Exerc"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e37236","DOI":"10.1371\/journal.pone.0037236","article-title":"Plasma and muscle myostatin in relation to type 2 diabetes","volume":"7","author":"Brandt","year":"2012","journal-title":"PLoS One"},{"key":"B28","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1055\/s-0035-1559663","article-title":"Plasma myostatin is only a weak predictor for weight maintenance in obese adults","volume":"123","author":"Tsioga","year":"2015","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12970-016-0160-9","article-title":"Serum reference value of two potential doping candidates-myostatin and insulin-like growth factor-I in the healthy young male","volume":"14","author":"Han","year":"2017","journal-title":"J Int Soc Sports Nutr"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1172\/JCI23606","article-title":"FGF-21 as a novel metabolic regulator","volume":"115","author":"Kharitonenkov","year":"2005","journal-title":"J Clin Invest"},{"key":"B31","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3109\/07435800.2011.558550","article-title":"Serum FGF-21 levels in type 2 diabetic patients","volume":"36","author":"Cheng","year":"2011","journal-title":"Endocr Res"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1210\/jc.2011-2823","article-title":"Relationship of serum fibroblast growth factor 21 with abnormal glucose metabolism and insulin resistance: the Baltimore Longitudinal Study of Aging","volume":"97","author":"Semba","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.2337\/db10-0193","article-title":"Obesity is a fibroblast growth factor 21 (FGF21)-resistant state","volume":"59","author":"Fisher","year":"2010","journal-title":"Diabetes"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1515\/hmbci-2016-0023","article-title":"Modulation of energy balance by fibroblast growth factor 21","volume":"30","author":"Cuevas-Ramos","year":"2016","journal-title":"Horm Mol Biol Clin Investig"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fendo.2018.00005\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,5,15]],"date-time":"2018-05-15T09:20:31Z","timestamp":1526376031000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fendo.2018.00005\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,31]]},"references-count":34,"alternative-id":["10.3389\/fendo.2018.00005"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2018.00005","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,31]]},"article-number":"5"}}